Context-dependent triggering of STING-interferon signaling by CD11b agonists supports anti-tumor immunity in mouse models and human cancer patients
X. Liu, G. D. Hogg, c. zuo, J. M. Baer, V. E. Lander, L. Kang, N. C. Borcherding, B. L. Knolhoff, R. E. Osterhout, A. V. Galkin, J. M. Bruey, L. L. Carter, C. Mpoy, J. K. Schwarz, H. Park, , D. DeNardo
This study identifies how CD11b agonists trigger STING-interferon signaling in tumor-associated macrophages to enhance anti-tumor immunity in mouse models and human cancer patients.
bioRxiv · Mar 22, 2022 · PreprintCancer Biology